Cogitum, 25 mg/ml 10 ml 30 pcs

The drug has a general tonic action. The active ingredient of the drug is acetylaminoyanthic acid – a biologically active compound found in the CNS.

The drug helps to normalize the processes of nervous regulation and has a stimulating effect.

Indications

Complex therapy of asthenic syndrome.

Pharmacological effect

A general tonic drug. The active principle of the drug is acetylaminosuccinic acid, a biologically active compound contained in the central nervous system.

The drug helps normalize nervous regulation processes and has a stimulating effect.

Special instructions

The drug can be used in elderly patients.

Impact on the ability to drive vehicles and operate machinery

No data available. It is unlikely that the drug can affect the ability to drive vehicles, operate machinery, or engage in other potentially hazardous activities.

Active ingredient

Acetylaminosuccinic acid

Composition

Active substance:

Contraindications

Hypersensitivity reactions to acetylaminosuccinic acid or any other component of the drug;
pregnancy (insufficient clinical data);
children under 7 years of age (no clinical data).

Side Effects

Allergic reactions are possible.

Interaction

No interactions with other drugs were observed.

Overdose

To date, no cases of overdose of the drug Cogitum have been reported. No toxic effects are expected.

Storage conditions

The drug should be stored out of the reach of children, protected from light, at a temperature not exceeding 25°C.

Shelf life

3 years

Manufacturer

Patheon France, France